AI Predicts Brain Tumor Growth, Could Personalize Treatment
This could help doctors track glioblastoma and adjust treatment sooner.
Deep Dive
arXivLabs is a framework that lets collaborators develop and share new arXiv features directly on the arXiv website. Both individuals and organizations that work with arXivLabs have embraced and accepted arXiv's values of openness, community, excellence, and user data privacy — and arXiv is committed to those values, working only with partners who adhere to them. If you have an idea for a project that will add value for arXiv's community, you can learn more about arXivLabs.
Key Points
- STRIDE is an AI that predicts brain tumor growth from MRI scans.
- It can forecast tumor size at any future date, helping personalize treatment.
- In tests, it was more accurate than other methods, but it's not yet ready for hospitals.
Why It Matters
Could lead to earlier, more personalized treatment for brain cancer patients, potentially extending lives.